TABLE 3.
Summary of the results by cognitive domain, effect metric and adjustments of the included studies.
| Global |
Memory |
Executive functions |
Attention |
||||||||||||||
| Study | Effect metric | Baseline levels | Final levels | Change in levels | Effect metric | Baseline levels | Final levels | Change in levels | Effect metric | Baseline levels | Final levels | Change in levels | Effect metric | Baseline levels | Final levels | Change in levels | Adjustments |
| Akbaraly et al., 2010 | F | NS | F | NS | F | NS | Age, gender, education or occupation, marital status, smoking, alcohol, physical activity, depression, coronary heart disease | ||||||||||
| Bangen et al., 2019 | β | – | – | NS | β | – | NS | NS | β | – | – | NS | Age, gender, education, smoking | ||||
| Creavin et al., 2012 | β | NS | β | – | β | NS | Age, social class, smoking, alcohol, premorbid cognition | ||||||||||
| Dearborn et al., 2014, women | β | – | NS | β | – | NS | β | NS | NS | Age, education, race-center, smoking, alcohol, history of coronary heart disease | |||||||
| Dearborn et al., 2014, men | β | – | NS | β | – | NS | β | NS | NS | ||||||||
| Gallagher et al., 2016 | β | NS | β | NS | Age, gender, duration of follow-up, cognitive status at baseline | ||||||||||||
| Harrison et al., 2015 | β | NS | NS | β | NS | NS | β | NS | NS | Gender, education, smoking, alcohol, marital status, history of stroke/ischemic heart disease/heart failure | |||||||
| Ho et al., 2008 | OR | – | – | Age, gender, education, smoking, alcohol, depression, level of leisure activities, APOE-e4, baseline MMSE, years of follow-up | |||||||||||||
| Katsumata et al., 2012 | β | NS | NS | β | NS | NS | β | – | NS | Age, gender, education | |||||||
| Kazlauskaite et al., 2020 | β | NS NS |
NS NS |
β | NS | NS | β | NS | – | Age, education, financial strain, site–race, smoking, alcohol, physical activity, sleep difficulty, depression, anxiety, vasomotor symptoms, menopausal stages/hormone therapy | |||||||
| Knopman et al., 2009 | β | NS | β | – | β | NS | Age, gender, education, race | ||||||||||
| Komulainen et al., 2007 | OR | NS | NS | OR | – | OR | NS | Age, education, depression | |||||||||
| Lee et al., 2010 | F | – | – | Age, gender, education, height, weight, baseline MMSE, years of follow-up | |||||||||||||
| Liu et al., 2013 | OR | NS | + | Smoking | |||||||||||||
| McEvoy et al., 2012, women | β | NS | NS | β | NS | NS |
β β |
NS NS |
– NS |
Age, education, depression, practice effect | |||||||
| McEvoy et al., 2012, men | β | NS | NS | β | NS | NS | β β |
NS NS |
NS NS |
||||||||
| Neergaard et al., 2017 | OR OR |
NS NS |
OR | NS | Age, education, smoking, alcohol, physical activity, hormone replacement therapy | ||||||||||||
| Overman et al., 2017 | β, OR β, OR |
NS NS |
β, OR | NS | Age, education, center, smoking, alcohol, depression, physical activity, heart disease/stroke | ||||||||||||
| Przybycien-Gaweda et al., 2020 | β | NS | – | NS | β | – | – | NS | β | – | – | NS | β β |
– NS |
– – |
NS NS |
Age, gender, education, smoking, alcohol, depression, leisure time activity, APOE-e4, cardiovascular disease/stroke |
| Raffaitin et al., 2011 | HR | – | – | HR | – | – | HR | – | NS | Age, gender, education, city center, smoking, depression, APOE-e4, cardiovascular disease, score on test at baseline | |||||||
| Shigaeff et al., 2017 | U | NS NS NS |
NS NS NS |
U | NS NS NS NS |
NS NS NS – |
U | NS NS |
NS NS |
Age, education | |||||||
| Soldevila-Domenech et al., 2021 | β | NS | β | NS | β | NS | Age, gender, education, IQ, smoking, baseline weight, prediabetes, diabetes, use of treatment for high cholesterol, use of tranquilizers or sedatives, intervention group |
||||||||||
| van den Berg et al., 2007 | β | NS | + | β | NS NS |
NS NS |
β | NS | + | β | NS | + | Gender, education, depression | ||||
| Viscogliosi et al., 2016 | std. β | – | – | Potentially confounding variables | |||||||||||||
| Viscogliosi et al., 2017 | std. β | NS | – | Age, education, marital status, depression, APOE-e4, cerebrovascular disease, baseline MMSE, incidence of ADLs disability, interaction term (MetS)*(baseline MMSE score) | |||||||||||||
| Wang et al., 2021 | F | – | – | Age, gender, education, professional characteristics, smoking, alcohol, living status | |||||||||||||
| Watts et al., 2013 | std. β | NS | NS | NS | std. β | NS | NS | NS | std. β | NS | NS | NS | Age, gender, education, APOE-e4 | ||||
| Wu and Chen, 2021 | – | HR, KM | NS | NS | HR, KM | – NS NS |
– NS NS |
Age, gender, education, smoking, coronary artery disease, hypertension, diabetes type 2 | |||||||||
| Xiong et al., 2006 | F | NS | Age at Time 3, education, smoking, alcohol, baseline TICS-m | ||||||||||||||
| Yaffe et al., 2004 | RR | NS | – | Age, education, race, alcohol, depression, stroke, statin use, baseline 3MS | |||||||||||||
| Yaffe et al., 2007 | β | NS | – | β | NS | NS | Age, gender, education, born in the USA, smoking, alcohol, depression, history of stroke, history of myocardial infarction, missing pattern indicator | ||||||||||
| Yaffe et al., 2009 | OR | NS | Age, education, race, depression, raloxifene hydrochloride treatment | ||||||||||||||
A plus (+) sign indicates a higher performance of participants with metabolic syndrome and a minus (–) sign a lower performance in the respective test. F, F-test (ANOVA); U, Mann–Whitney test; β, beta coefficient; std. β, standardized beta coefficient; OR, odds ratio; HR, hazard ratio; RR, risk ratio; KM, Kaplan–Meier curves; NS, not significant; MetS, metabolic syndrome; APOE-e4, e4 allele of the apolipoprotein E; MMSE, Mini-Mental State Examination; IQ, intelligence quotient; ADLs, Activities of Daily Living; TICS-m, Modified Telephone Interview for Cognitive Status; 3MS, Modified Mini-Mental State Examination; USA, United States of America.